rs755405205
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_021098.3(CACNA1H):c.5519T>G(p.Phe1840Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000643 in 1,400,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. F1840F) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.5519T>G | p.Phe1840Cys | missense_variant | Exon 33 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.5534T>G | p.Phe1845Cys | missense_variant | Exon 32 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.5537T>G | p.Phe1846Cys | missense_variant | Exon 32 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.5501T>G | p.Phe1834Cys | missense_variant | Exon 32 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.5534T>G | p.Phe1845Cys | missense_variant | Exon 33 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.5519T>G | p.Phe1840Cys | missense_variant | Exon 33 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.5480T>G | p.Phe1827Cys | missense_variant | Exon 33 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.5501T>G | p.Phe1834Cys | missense_variant | Exon 32 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.5462T>G | p.Phe1821Cys | missense_variant | Exon 32 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.5519T>G | p.Phe1840Cys | missense_variant | Exon 33 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.5501T>G | p.Phe1834Cys | missense_variant | Exon 32 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.5519T>G | p.Phe1840Cys | missense_variant | Exon 33 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.5519T>G | p.Phe1840Cys | missense_variant | Exon 33 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.5519T>G | p.Phe1840Cys | missense_variant | Exon 33 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.5519T>G | non_coding_transcript_exon_variant | Exon 33 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.*1471T>G | non_coding_transcript_exon_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.*600T>G | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*3370T>G | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*4963T>G | non_coding_transcript_exon_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.*493T>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.*378T>G | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.*1131T>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.*186T>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.*186T>G | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.5501T>G | non_coding_transcript_exon_variant | Exon 32 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.5519T>G | non_coding_transcript_exon_variant | Exon 33 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.5519T>G | non_coding_transcript_exon_variant | Exon 33 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.*635T>G | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000637236.3 | n.*1471T>G | 3_prime_UTR_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.*600T>G | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*3370T>G | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*4963T>G | 3_prime_UTR_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.*493T>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.*378T>G | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.*1131T>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.*186T>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.*186T>G | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711488.1 | n.*635T>G | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.0000559 AC: 9AN: 160970 AF XY: 0.0000587 show subpopulations
GnomAD4 exome AF: 0.00000643 AC: 9AN: 1400612Hom.: 0 Cov.: 32 AF XY: 0.00000724 AC XY: 5AN XY: 691036 show subpopulations
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.5519T>G (p.F1840C) alteration is located in exon 33 (coding exon 32) of the CACNA1H gene. This alteration results from a T to G substitution at nucleotide position 5519, causing the phenylalanine (F) at amino acid position 1840 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 1840 of the CACNA1H protein (p.Phe1840Cys). This variant is present in population databases (rs755405205, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 572075). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CACNA1H protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
PP3 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at